Literature DB >> 19297623

p110gamma and p110delta isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and disease.

Aurore Saudemont1, Fabien Garçon, Hakim Yadi, Marta Roche-Molina, Nayoung Kim, Anne Segonds-Pichon, Alfonso Martín-Fontecha, Klaus Okkenhaug, Francesco Colucci.   

Abstract

The mechanisms that regulate NK cell trafficking are unclear. Phosphoinositide-3 kinases (PI3K) control cell motility and the p110gamma and p110delta isoforms are mostly expressed in leukocytes, where they transduce signals downstream of G protein coupled receptors (GPCR) or tyrosine kinase receptors, respectively. Here, we set out to determine the relative contribution of p110gamma and p110delta to NK cell migration in mice. Using a combination of single-cell imaging analysis of transgenic cells reporting on PI3K activity in real time and small molecule inhibitors of p110gamma and p110delta, we show here that the tyrosine-kinase coupled p110delta is linked to GPCR signaling and, depending on the GPCR, may even be preferentially activated over p110gamma. Using gene-targeted mice, we showed that both isoforms were essential for NK cell chemotaxis to CXCL12 and to CCL3 and, in vivo, for normal NK cell migration during pregnancy and to the inflamed peritoneum. By contrast, only p110delta was indispensable for chemotaxis to S1P and CXCL10 and for NK cell distribution throughout lymphoid and nonlymphoid tissues and for extravasation to tumors. These results implicate p110delta downstream of GPCRs in NK cells and highlight its nonredundant role as a key regulator of NK cell trafficking in health and disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19297623      PMCID: PMC2667007          DOI: 10.1073/pnas.0808594106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

Review 1.  Role of chemokines in the biology of natural killer cells.

Authors:  Michael J Robertson
Journal:  J Leukoc Biol       Date:  2002-02       Impact factor: 4.962

Review 2.  Chemokine signalling: pivoting around multiple phosphoinositide 3-kinases.

Authors:  Adam P Curnock; Marisa K Logan; Stephen G Ward
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

3.  NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases.

Authors:  Simona Zompi; Jessica A Hamerman; Kouetsu Ogasawara; Edina Schweighoffer; Victor L J Tybulewicz; James P Di Santo; Lewis L Lanier; Francesco Colucci
Journal:  Nat Immunol       Date:  2003-05-11       Impact factor: 25.606

Review 4.  Rapid leukocyte integrin activation by chemokines.

Authors:  Carlo Laudanna; Ji Yun Kim; Gabriela Constantin; Eugene Butcher
Journal:  Immunol Rev       Date:  2002-08       Impact factor: 12.988

Review 5.  PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond?

Authors:  Christian Rommel; Montserrat Camps; Hong Ji
Journal:  Nat Rev Immunol       Date:  2007-02-09       Impact factor: 53.106

6.  Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110delta.

Authors:  Carol Sawyer; Justin Sturge; Dorothy C Bennett; Michael J O'Hare; William E Allen; Jennifer Bain; Gareth E Jones; Bart Vanhaesebroeck
Journal:  Cancer Res       Date:  2003-04-01       Impact factor: 12.701

Review 7.  Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer.

Authors:  R Katso; K Okkenhaug; K Ahmadi; S White; J Timms; M D Waterfield
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

Review 8.  Phosphoinositide 3-kinase: a key biochemical signal for cell migration in response to chemokines.

Authors:  Y Sotsios; S G Ward
Journal:  Immunol Rev       Date:  2000-10       Impact factor: 12.988

9.  Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.

Authors:  Loredana Ruggeri; Marusca Capanni; Elena Urbani; Katia Perruccio; Warren D Shlomchik; Antonella Tosti; Sabrina Posati; Daniela Rogaia; Francesco Frassoni; Franco Aversa; Massimo F Martelli; Andrea Velardi
Journal:  Science       Date:  2002-03-15       Impact factor: 47.728

10.  CXCL12 expression by invasive trophoblasts induces the specific migration of CD16- human natural killer cells.

Authors:  Jacob Hanna; Ori Wald; Debra Goldman-Wohl; Diana Prus; Gal Markel; Roi Gazit; Gil Katz; Ronit Haimov-Kochman; Nobutaka Fujii; Simcha Yagel; Amnon Peled; Ofer Mandelboim
Journal:  Blood       Date:  2003-05-01       Impact factor: 22.113

View more
  36 in total

Review 1.  The emerging mechanisms of isoform-specific PI3K signalling.

Authors:  Bart Vanhaesebroeck; Julie Guillermet-Guibert; Mariona Graupera; Benoit Bilanges
Journal:  Nat Rev Mol Cell Biol       Date:  2010-04-09       Impact factor: 94.444

2.  CXCL12-induced macropinocytosis modulates two distinct pathways to activate mTORC1 in macrophages.

Authors:  Regina Pacitto; Isabella Gaeta; Joel A Swanson; Sei Yoshida
Journal:  J Leukoc Biol       Date:  2016-10-17       Impact factor: 4.962

Review 3.  Natural killer cell responses to viral infection.

Authors:  Joshua D Brandstadter; Yiping Yang
Journal:  J Innate Immun       Date:  2011-03-12       Impact factor: 7.349

Review 4.  PI3Ks in lymphocyte signaling and development.

Authors:  Klaus Okkenhaug; David A Fruman
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

Review 5.  PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting.

Authors:  Lauren M Thorpe; Haluk Yuzugullu; Jean J Zhao
Journal:  Nat Rev Cancer       Date:  2015-01       Impact factor: 60.716

6.  Immature NK cells, capable of producing IL-22, are present in human uterine mucosa.

Authors:  Victoria Male; Tiffany Hughes; Susan McClory; Francesco Colucci; Michael A Caligiuri; Ashley Moffett
Journal:  J Immunol       Date:  2010-08-27       Impact factor: 5.422

7.  PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans.

Authors:  Dalya R Soond; Elisa Bjørgo; Kristine Moltu; Verity Q Dale; Daniel T Patton; Knut Martin Torgersen; Fiona Galleway; Breda Twomey; Jonathan Clark; J S Hill Gaston; Kjetil Taskén; Peter Bunyard; Klaus Okkenhaug
Journal:  Blood       Date:  2010-01-15       Impact factor: 22.113

8.  PD-L1 Mediates Dysfunction in Activated PD-1+ NK Cells in Head and Neck Cancer Patients.

Authors:  Fernando Concha-Benavente; Benjamin Kansy; Jessica Moskovitz; Jennifer Moy; Uma Chandran; Robert L Ferris
Journal:  Cancer Immunol Res       Date:  2018-10-03       Impact factor: 11.151

9.  PTEN regulates natural killer cell trafficking in vivo.

Authors:  Jeffrey W Leong; Stephanie E Schneider; Ryan P Sullivan; Bijal A Parikh; Bryan A Anthony; Anvita Singh; Brea A Jewell; Timothy Schappe; Julia A Wagner; Daniel C Link; Wayne M Yokoyama; Todd A Fehniger
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

Review 10.  Targeting the phosphoinositide 3-kinase pathway in hematologic malignancies.

Authors:  Elias Jabbour; Oliver G Ottmann; Michael Deininger; Andreas Hochhaus
Journal:  Haematologica       Date:  2014-01       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.